MedPath
NMPA Approval

Taletrectinib Adipate Capsules

国药准字H20240044

December 17, 2024

Drug Information

己二酸他雷替尼胶囊

达伯乐

胶囊剂

0.2g(以C₂₃H₂₄FN₅O计)

化学药品

December 17, 2024

Company Information

Applicant Company

浙江省杭州市钱塘区下沙街道福城路501号银海科创中心6幢401室-19

Manufacturing Company

天津开发区第七大街71号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

己二酸他雷替尼胶囊 - NMPA 批准文号 | MedPath